We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current APRE market cap is 16.85M. The company's latest EPS is USD -2.6287 and P/E is -1.20.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 319k | 14k | 381k | 561k | 355k |
| Operating Income | -3.52M | -3.68M | -3.15M | -3.85M | -4.1M |
| Net Income | -3.2M | -3.44M | -2.81M | -3.47M | -3.78M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 583k |
| Operating Income | -29.54M | -52.81M | -37.45M | -113.39M | -15.47M |
| Net Income | -28.06M | -53.48M | -37.13M | -112.66M | -14.29M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.77M | 22.65M | 33.2M | 29.96M | 26.89M |
| Total Liabilities | 4.17M | 4.39M | 2.97M | 3.09M | 3.64M |
| Total Equity | 20.29M | 16.95M | 28.92M | 25.56M | 21.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 133.61M | 92.81M | 56.82M | 30.16M | 22.65M |
| Total Liabilities | 9.36M | 15.41M | 7.32M | 3.2M | 4.39M |
| Total Equity | 124.24M | 77.4M | 49.51M | 25.64M | 16.95M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.44M | -12.18M | -3.94M | -7.58M | -10.05M |
| Investing | -86k | -93k | -8k | -15k | -15k |
| Financing | 5.14M | 5.14M | 14.71M | 14.69M | 14.69M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.71M | -41.8M | -37.69M | -25.01M | -12.18M |
| Investing | -31k | -26k | N/A | N/A | -93k |
| Financing | 92.58M | 151k | 1.75M | 683k | 5.14M |
| Market Cap | 16.85M |
| Price to Earnings Ratio | -1.20 |
| Price to Sales Ratio | 29.36 |
| Price to Cash Ratio | 0.79 |
| Price to Book Ratio | 0.94 |
| Dividend Yield | - |
| Shares Outstanding | 5.43M |
| Average Volume (1 week) | 20.45k |
| Average Volume (1 Month) | 24.2k |
| 52 Week Change | -15.53% |
| 52 Week High | 8.8465 |
| 52 Week Low | 2.1501 |
| Spread (Intraday) | 0.07 (2.21%) |
| Company Name | Aprea Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.aprea.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
